Hepatitis C virus E2 binding protein

Details Hepatitis C virus E2 binding protein Hepatitis C virus E2 binding protein

2008-01-22

2008-01-22

Lucas, Zachariah (Department: 1648)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C435S004000, C435S005000, C435S007100, C435S007900, C530S350000, C530S387100

Reexamination Certificate

active

07320875

ABSTRACT:
HCV assays are described. The assays utilize a 24 kd protein capable of binding the E2 envelope protein of hepatitis C virus (HCV), or functionally equivalent variants or fragments of the 24 kd protein.

REFERENCES:
patent: 6682909 (2004-01-01), Nakano et al.
patent: 0 318 216 (1988-11-01), None
patent: 0 388 232 (1990-03-01), None
patent: WO 93/04205 (1993-03-01), None
patent: WO 96/04376 (1996-02-01), None
patent: WO 96/05513 (1996-02-01), None
Chien et al., “Diagnosis of Hepatitis C Virus (HCV) Infection Using an Immunodominant Chimeric Polyprotein to Capture Circulating Antibodies: Reevaluation of the Role of HCV in Liver Disease”, Proc. Natl. Acad. Sci. USA., (1992) 89:10011-10015.
Choo et al., “Genetic Organization and Delivery of the Hepatitis C Virus”, Proc. Natl. Acad. Sci. USA., (1991) 88:2451-2455.
Germi et al., Journal of Medical Virology, 68:206-215 (2002).
Gething et al., “Contraction of Influenza Haemagglutinin Genes that Code for Intracellular and Secreted Forms of the Protein”, Nature (1982) 300:598-603.
Laemmli, “Cleavage of Structural Proteins During the Assembly of the Had of Bacteriophage T4”, Nature (1970) 227:680-685.
Morre et al., “Plasma and Internal Membranes from Cultured Mammalian Cells”, Methods in Enzymology (1994) 228:448-450.
Rosa et al., “A Quantitative Test to Estimate Neutralizing Antibodies to the Hepatitis C Virus: Cytofluorimetric Assessment of Envelope Glycoprotein 2 Binding to Target Cells”, Proc. Natl. Acad. Sci. USA., (1996) 93:1756-1763.
Spaete et al., “Characterization of the Hepatitis C Virus E2/NS1 Gene Product Expressed in Mammalian Cells”, Virology (1992) 188:819-830.
Minutello et al., Journal of Hepatology, 17 (Suppl. 1):55-56, 1992.
Rice, C.M., Hepatology 29(3):990-992, 1999.
Rowlands et al., pp. 795-808, in Henry, J.B., ed., Clinical Diagnosis & Management by Laboratory Methods, 18thed., W.B. Saunders Compnay, Philadelphia, 1991.
Shimonaka et al.., Journal of Biological Chemistry, 269(19):14284-14289, 1994.
Bowie et al.., Science, 247:1306-1310 (1990).
Burgess et al., Journal of Cell Biology, 111:2129-2138 (1990).
Lazar et al.., Molecular and Cellular Biology, 8:1247-1252 (1988).
Levy et al., Structure and Menbrane Topology of TAPA-1, The Journal of Biological Chemistry 266(22):14597-14602 (1991)..,.
Pileri et al., Binding of Hepatitis C Virus to CD81, Science 282:938-941 (1998).
Levy et al., “CD81 (TAPA-1): A Molecule Involved in Signal Transduction and Cell Adhesion in the Immune System,” Annu. Rev. Immunol., 16:89-109 (1998).

Affiliated with

Also associated with

Rating

Hepatitis C virus E2 binding protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hepatitis C virus E2 binding protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis C virus E2 binding protein will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2782719